MAPT and Alzheimer disease: This study aimed to develop and evaluate a multidomain speech analysis framework to support cognitive screening, biomarker prediction within the amyloid, tau and neurodegeneration (ATN) framework, and estimation of cognitive function across the AD continuum.<h4>Methods</h4>This study analyzed speech from 2,320 individuals spanning the cognitive spectrum-including those with subjective cognitive decline (SCD), MCI, and Alzheimer's disease dementia (ADD)-using three spoken tasks (∼3 min) and extracted multidomain features including acoustic, lexical, syntactic, and semantic features.